Bio Solution Co Ltd
KOSDAQ:086820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bio Solution Co Ltd
Other Current Assets
Bio Solution Co Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bio Solution Co Ltd
KOSDAQ:086820
|
Other Current Assets
₩371.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Current Assets
₩165B
|
CAGR 3-Years
43%
|
CAGR 5-Years
41%
|
CAGR 10-Years
20%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Other Current Assets
₩19.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Current Assets
₩2.3B
|
CAGR 3-Years
76%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Current Assets
₩6.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
44%
|
CAGR 10-Years
38%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Current Assets
₩1.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
Bio Solution Co Ltd
Glance View
Bio Solution Co. Ltd. engages in the development of cell therapy products and stem cell applied technologies based on tissue engineering and stem cell technologies. The company is headquartered in Seoul, Seoul and currently employs 97 full-time employees. The company went IPO on 2018-08-20. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The firm manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The firm also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.
See Also
What is Bio Solution Co Ltd's Other Current Assets?
Other Current Assets
371.9m
KRW
Based on the financial report for Sep 30, 2025, Bio Solution Co Ltd's Other Current Assets amounts to 371.9m KRW.
What is Bio Solution Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
28%
Over the last year, the Other Current Assets growth was 51%. The average annual Other Current Assets growth rates for Bio Solution Co Ltd have been 28% over the past three years , 28% over the past five years .
